|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008838,
umls-concept:C0024121,
umls-concept:C0205179,
umls-concept:C0208407,
umls-concept:C0681850,
umls-concept:C0684224,
umls-concept:C0684249,
umls-concept:C1257890,
umls-concept:C1512888,
umls-concept:C1550501,
umls-concept:C1706203,
umls-concept:C2349001,
umls-concept:C2603343,
umls-concept:C2697811
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2000-4-12
|
|
pubmed:abstractText |
A phase III trial, Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors (CATAPULT I), was designed to determine the efficacy and safety of tirapazamine plus cisplatin for the treatment of non-small-cell lung cancer (NSCLC).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:ArcenasAA,
pubmed-author:AyoubJJ,
pubmed-author:BergmanBB,
pubmed-author:BoyerMM,
pubmed-author:ButlerT WTW,
pubmed-author:ClarkPP,
pubmed-author:DunlopDD,
pubmed-author:ElissonL OLO,
pubmed-author:GatzemeierUU,
pubmed-author:HirseSS,
pubmed-author:OlverII,
pubmed-author:ReyAA,
pubmed-author:RichardsonGG,
pubmed-author:TalbotDD,
pubmed-author:TreatJJ,
pubmed-author:VescioRR,
pubmed-author:VialletJJ,
pubmed-author:von PawelJJ,
pubmed-author:von RoemelingRR
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1351-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10715308-Adult,
pubmed-meshheading:10715308-Aged,
pubmed-meshheading:10715308-Antineoplastic Agents,
pubmed-meshheading:10715308-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10715308-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:10715308-Cell Hypoxia,
pubmed-meshheading:10715308-Cisplatin,
pubmed-meshheading:10715308-Drug Synergism,
pubmed-meshheading:10715308-Female,
pubmed-meshheading:10715308-Humans,
pubmed-meshheading:10715308-Lung Neoplasms,
pubmed-meshheading:10715308-Male,
pubmed-meshheading:10715308-Middle Aged,
pubmed-meshheading:10715308-Survival Analysis,
pubmed-meshheading:10715308-Triazines
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Tirapazamine plus cisplatin versus cisplatin in advanced non-small-cell lung cancer: A report of the international CATAPULT I study group. Cisplatin and Tirapazamine in Subjects with Advanced Previously Untreated Non-Small-Cell Lung Tumors.
|
|
pubmed:affiliation |
Asklepios Fachkliniken München-Gauting, Gauting, and Hospital Grosshansdorf, Hamburg, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase III
|
